Cite
HARVARD Citation
Gadgeel, S. et al. (2019). Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study. Lung cancer. pp. 105-112. [Online].